Dr Emma Simpson
BSc, PhD
Population Health, School of Medicine and Population Health
Research Fellow
e.l.simpson@sheffield.ac.uk
+44 114 222 0708
+44 114 222 0708
Regent Court (ScHARR)
Full contact details
Dr Emma Simpson
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
ºù«Ӱҵ
S1 4DA
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
ºù«Ӱҵ
S1 4DA
- Profile
-
I am a member of ScHARR-TAG. I have a PhD in psychology, and a background in health services research.
- Research interests
-
Research interests include mental health, arthritis, cardiovascular disease and oncology. I specialise in systematic reviews of clinical effectiveness, with an interest in systematic reviewing methodology.
Current projects
I have recently worked on a number of projects for the Health Technology Assessment Programme, and for the National Institute of Health and Care Excellence. Topics include rheumatoid arthritis, cardiovascular disease and oncology.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Discover Psychology, 4.
- . Bone, 130.
- . Health Technology Assessment, 20(35), 1-610.
- . PharmacoEconomics, 33(11), 1187-1194.
- . Health Technol Assess, 18(10), 1-252.
- . Health Technol Assess, 17(36), 1-vi.
- . Br J Surg, 100(9), 1128-1137.
- . Pharmacoeconomics, 31(4), 269-275.
- . Health Technol Assess, 13(17), iii-154.
- . Health Technol Assess, 13(2), iii-91.
- . BMJ, 325(7375), 1265.
All publications
Journal articles
- . Discover Psychology, 4.
- . Health Technology Assessment, 24(29).
- . Bone, 130.
- . International Journal of Technology Assessment in Health Care.
- . PharmacoEconomics, 37(1), 7-18.
- . PharmacoEconomics.
- . PharmacoEconomics, 36, 769-778.
- . Pharmacoeconomics, 36(12), 1427-1437.
- . Health Technology Assessment, 22(20).
- . Health Technology Assessment, 21(71), 1-258.
- . Journal of Rheumatology, 44(7), 973-980.
- . Health Technology Assessment, 20(35), 611-614.
- . PharmacoEconomics, 34(8), 741-750.
- . PharmacoEconomics, 34(7), 673-680.
- . Health Technology Assessment, 20(35), 1-610.
- . PharmacoEconomics, 33(11), 1187-1194.
- . PharmacoEconomics, 33(3), 225-233.
- . Angiology, 65(3), 190-197.
- . Health Technol Assess, 18(10), 1-252.
- . British Journal of Surgery, 100(13), 1838-1839.
- . Health Technol Assess, 17(36), 1-vi.
- . Br J Surg, 100(9), 1128-1137.
- . PharmacoEconomics, 31(6), 471-478.
- . Pharmacoeconomics, 31(4), 269-275.
- . Clinical Oncology, 24(10).
- . Br J Surg, 99(12), 1630-1638.
- . Health Technol Assess, 15(40), 1-210.
- . Journal of Urology, 186(2), 534-535.
- . J Infect, 62(1), 14-25.
- . Health Technol Assess, 14(47), 1-iv.
- . Health Technol Assess, 14 Suppl 1, 63-67.
- A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism.. J. Simulation, 4, 14-23.
- . Eur J Cancer, 45(16), 2749-2758.
- . Health Technol Assess, 13(17), iii-154.
- . Health Technol Assess, 13(11), iii-246.
- . Value Health, 12(5), 657-665.
- . Health Technology Assessment, 13, iii-50.
- . Health Technol Assess, 13(5), iii.
- . Health Technol Assess, 13(2), iii-91.
- . Health Technol Assess, 11(26), iii-134.
- . Health Technol Assess, 11(40), 1-144.
- . Psychiatric Bulletin, 30(2), 67-69.
- User and carer involvement in mental health services: from rhetoric to science. BRIT J PSYCHIAT, 183, 89-91.
- . BMJ, 325(7375), 1265.
- A Guide to Involving Users, Ex-users and Carers in Mental Health Service Planning, Delivery or Research: a health technology approach. A Guide to Involving Users, Ex-users and Carers in Mental Health Service Planning, Delivery or Research: A Health Technology Approach.
- .
- .
- . Health Technology Assessment, 14(Suppl 1), 63-67.
- . SN Comprehensive Clinical Medicine.
Chapters
Conference proceedings papers
- The Cost-Effectiveness of Biologic DMARDs in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional DMARDs. ISPOR 17th Annual European Congress, Vol. Value in Health, Vol. 17, Issue 7, A380. Amsterdam, The Netherlands
- The cost-effectiveness of biologic DMARDs in patients with severe or mild-to-severe RA after conventional DMARDs. SMDM (Society for Medical Decision Making) conference 15th Biennial European Meeting. Antwerp, Belgium
- . Value in Health, Vol. 17(7) (pp A380-A380)
- Systematic review and meta-analysis of additional technologies to enhance angioplasty for infra-inguinal peripheral arterial occlusive disease.. HTAi 10th Annual Meeting. Seoul, Korea
- . Value in Health, Vol. 15(7) (pp A633-A633)
- Cost-effectiveness of spinal cord stimulation for chronic pain of neuropathic origin in the UK. IFORS (International Federation of Operational Research Societies Conference). Sandton South Africa
- The clinical effectiveness of oseltamivir, amantadine and zanamivir for the prophylaxis of influenza: A systematic review. Poster M17.4. HTAi 2008. Montreal Canada
- The cost-effectiveness of thrombophilia testing in patients with idiopathic venous thromboembolism. Abstract 3262. 29th Annual Meeting of The Society for Medical Decision Making (SMDM). Pittsburgh, Pennsylvania, USA
Reports
- A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy
Posters
- PMS4 - RHEUMATOID ARTHRITIS TREATED WITH SIX-MONTHS OF FIRST-LINE BIOLOGIC OR BIOSIMILAR THERAPY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.
- Diagnostic accuracy of echocardiography for co-existing pathologies in atrial fibrillation patients: systematic review. HTAi 9th Annual Meeting.
- Ultrasound to Guide Treatment Decisions in Rheumatoid Arthritis.